Navigation Links
So Long, Old Friend: The End of the Blockbuster Drug Era? What 2008 Holds for Bringing Drugs to Market
Date:11/15/2007

rtunity to have face-to-face dialogues with top policymakers and executives. The Summit is aimed at industry executives in all areas of responsibility who want to create successful strategies for dealing with FDA and CMS. Attendees will get practical, real-life lessons from some of the most experienced pharmaceutical and biotechnology executives on how they handle regulatory obstacles, and will also be able to benchmark their regulatory strategy against all other pharmaceutical and biotechnology companies.

Among the panels and participants scheduled for the Summit are:

- Did FDA Kill the Blockbuster? The Impact of FDA Changes on Research

and Development

-- Pfizer President, Global R&D Martin Mackay

-- Bristol-Myers Squibb SVP R&D Brian Daniels

-- Novartis SVP Global Clinical Development & Medical Affairs Glenn

Gormley

- Personalized Medicine: How Industry and Government can Make it Happen

-- Hoffmann La-Roche Inc. CEO George Abercrombie

- FDAAA and the New Active Surveillance System: What Does Data Mining

Mean for the Pharmaceutical Industry?

-- Engelberg Center for Health Care Reform Director, Former CMS

Administrator & FDA Commissioner Mark McClellan

-- FDA Assistant Commissioner for Policy Jeffrey Shuren

-- i3 Drug Safety SVP Alec Walker

- Paying for Innovation: CMS' Approach to Coverage

-- CMS Coverage & Analysis Group Director Steve Phurrough

- How the Government and Payors will Impact the Rx Market

-- CMS Center for Beneficiary Choices Chief Medical Officer Jeffrey

Kelman;

-- Former CMS Senior Advisor Larry Kocot;

-- Former Wellpoint Chief Pharmacy Officer and Founder of Doc Rock

Presents Robert Seidman

- Pharma in the Crosshairs: What are the Boundaries for Acceptable

Marketing?

-- First Assistant US Attorney, Boston Michael Loucks

-- Sidley
'/>"/>

SOURCE Windhover Information Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
2. Merck Will Obtain Blockbuster Antidiabetic Drug Sales in Type 2 Diabetes Market by 2011
3. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
4. Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments
5. Nobel Award in Medicine Holds Strong Messsage for Animal Activists
6. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
7. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
8. Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions
9. First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs
10. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
11. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 2014 Research and Markets ... "Spectroscopy Equipment and Accessories - Global ... offering. This report analyzes ... Accessories in US$ Thousands by the following ... Spectrometers, NMR-EPR Spectrometers, Near Infrared (NIR) Spectrometers, ...
(Date:8/19/2014)... In November 2012, the European Union (EU) mandated ... in a new PSUR – responding to the increasing need ... a drug. Adopted in many regions, the main objectives of ... comprehensive and critical analysis of new or emerging information on ... new evidence of the potential benefits of a drug; and ...
(Date:8/19/2014)... , Aug. 19, 2014 /PRNewswire/ - iCo Therapeutics ... ICOTF), today reported results of its Oral Amphotericin ... HIV reservoirs.  The study, conducted by ImmuneCarta®, the ... in vitro effectiveness of Oral Amp B ... present in individuals despite intensive treatment with antiretroviral ...
(Date:8/18/2014)... 2014 Deep Research Report on ... and in-depth research report on the China Linalool ... including its definition, classification, application, and industry chain ... covers the international market analysis, including China’s domestic ... macroeconomic environment & economic situation analysis. The report ...
Breaking Biology Technology:Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 2Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 4
... 29, 2011 University of Utah chemists developed a method ... speed chemical reactions and are crucial for producing energy, chemicals ... also made a discovery that will make it easier to ... properties of catalysts interact to affect how well a catalyst ...
... is a byproduct of nearly all electrical devices and ... aircraft or operating a power plant. Engineering researchers at ... lead to techniques for better capturing and putting this ... marble-sized pellets of the new material are aluminum and ...
... 29, 2011 Today BioSpace , the leading ... Biotech Beach™ Hotbed Campaign, marking the 14th edition. ... organizations across Southern California. Each company,s brand is added ... that is promoted online as well as at industry ...
Cached Biology Technology:Building better catalysts 2Building better catalysts 3Rensselaer engineers 'cook' promising new heat-harvesting nanomaterials in microwave oven 2BioSpace Spotlights Southern California's Life Science Community 2
(Date:8/20/2014)... a study of 158 pregnant teenagers in Rochester, NY, ... intentional consumption of ice, cornstarch, vacuum dust, baby powder ... Cornell study. , Moreover, such teens had significantly lower ... eat nonfood substances. , Pregnant teens, regardless of pica, ... lead to iron deficiency and anemia. Low iron in ...
(Date:8/20/2014)... Multiple fires are visible in in this image of ... Many of these were most likely intentionally set in ... of a forest or stand of trees where the ... of deforestation include conversion of forestland to farms, ranches, ... the dark green of the Amazon Rainforest in the ...
(Date:8/20/2014)... athletes who have suffered concussions ready to return to ... that high school athletes who head back on the ... significant regression in their abilities to simultaneously walk and ... in changes in their balance and/or altered walking speed, ... the 12 had returned to activity in less than ...
Breaking Biology News(10 mins):Pica in pregnant teens linked to low iron 2Recovery reversal seen in Oregon study of returning concussed athletes 2Recovery reversal seen in Oregon study of returning concussed athletes 3
... COLUMBUS, Ohio Reversing a protein deficiency through gene ... survival in mice that serve as a model for the ... This muscle-wasting disease results when a child,s motor neurons ... muscles produce insufficient amounts of what is called survival ...
... 2010) -- IEEE-USA President Evelyn Hirt praises the Intel-led ... to support investment in U.S.-based technology companies over the ... increase jobs for college graduates. "We commend the ... businesses and for creating high-skill job opportunities for U.S. ...
... The increasing prevalence of type 2 diabetes places a huge ... healthcare systems. Half of all heart attacks and stroke cases, ... the effects of this metabolic syndrome. In Germany alone, some ... number of cases worldwide is projected to reach 370 million ...
Cached Biology News:Study: Gene therapy reverses effects of lethal childhood muscle disorder in mice 2Study: Gene therapy reverses effects of lethal childhood muscle disorder in mice 3Study: Gene therapy reverses effects of lethal childhood muscle disorder in mice 4IEEE-USA President praises US job growth initiative by Invest in America Alliance 2The pig and its pancreas 2The pig and its pancreas 3
... The ULS cDNA Synthesis and Labeling Kit ... hybridization experiments. First unmodified cDNA is made ... cDNA using an Oligo(dT) primer. Unlike other ... used in the reverse transcription reaction. This ...
... Dot Blot Kits overcome this limitation and ... a wide range in low-density protein array ... They are ideal for performing reverse-phase protein ... for the presence of low abundant antigens. ...
AC input: 50-60 Hz230 V...
... arraying proteins of interest with sensitive ... DiscoverLight Protein Array Kits allow for ... lysate or antibody in a low-density ... designed nitrocellulose membranes with a 384-grid ...
Biology Products: